Abbott Initiates Clinical Trial of Three-month Dual Antiplatelet Therapy Following Implantation with XIENCE Coronary Stent

- Trial will evaluate amount of time patients at high risk of bleeding should receive blood thinning medicine after treatment with XIENCE
Source: Abbott.com - Category: Pharmaceuticals Source Type: news